Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Back to Polyneuropathy

Polyneuropathy — NIH Grants & Funding

Active and recent NIH-funded research on Polyneuropathy. Data from NIH RePORTER, last 36 months.

MONDO:0001824

Looking for specific grants? The Recent Research tab lets you search and filter by topic.

Funding Landscape

Polyneuropathy has active NIH research funding with 6 funded grants totaling $6.9M.

6funded grants from NIH

Portfolio: $3.3MCumulative: $6.9M1 active5 completed7 PIs6 institutions

By Research Theme

Clinical

Biomarker / Dx

Basic Science

Epi / Nat. History

Funding by Fiscal Year

NIH fiscal year (Oct–Sep)

$2.4M

FY22

$2.1M

FY23

$1.2M

FY24

$1.2M

FY25

By Funding Mechanism

R01

K23

R61

U44

Funding Gap Analysis

Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Polyneuropathy. Strongest funded area: Biomarker / Diagnostics. Largest gap: Translational / Drug Development.

Translational / Drug DevelopmentPublished, Not NIH-Funded

9 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for polyneuropathy. Existing research activity suggests this may be a viable area for grant applications.

Adjacent Research(15 grants)

These grants mention Polyneuropathy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.

Other(15)

OtherR00Active

The Role of Tau Phosphorylation in Diabetic Peripheral Neuropathy

NICHOLS, JAMES·UNIVERSITY OF CENTRAL FLORIDA·ORLANDO, FL

$747,000 (FY2025)

NIH RePORTER

OtherR01Active

Uncovering early signals of hereditary TTR amyloidosis in minority populations at high genetic risk

Kontorovich, Amy·ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI·NEW YORK, NY

$601,806 (FY2025)

NIH RePORTER

OtherR01Active

Modulation of CSF1R Signaling to Treat Inflammatory Neuropathies

SHEIKH, KAZIM·UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON·HOUSTON, TX

$569,135 (FY2026)

NIH RePORTER

OtherR01Active

The role of SARM1 in neuroinflammation-mediated axonal damage

Diantonio, Aaron et al.·WASHINGTON UNIVERSITY·SAINT LOUIS, MO

$550,543 (FY2025)

NIH RePORTER

OtherR01Active

Cellular and Genetic Mechanisms of Autoimmune Diabetes Associated Neuritis

Racine, Jeremy·JACKSON LABORATORY·BAR HARBOR, ME

$537,140 (FY2025)

NIH RePORTER

OtherR15Active

Mechanisms of Peripheral Nerve Injury and Recovery in a Zebrafish Demyelination Model

Petersen, Sarah·KENYON COLLEGE·GAMBIER, OH

$454,424 (FY2025)

NIH RePORTER

OtherR21Active

Ubiquitin Ligase TRIM39 Control of Zika Virus Infection

HORVATH, CURT·NORTHWESTERN UNIVERSITY·CHICAGO, IL

$200,000 (FY2026)

NIH RePORTER

OtherR21Active

Development of ganglioside specific IgGs for the treatment of Guillian-Barré Syndrome

Szymanski, Christine·UNIVERSITY OF GEORGIA·ATHENS, GA

$182,243 (FY2025)

NIH RePORTER

OtherZIACompleted

Mechanisms of Pain and Immune Processes

Mannes, Andrew·CLINICAL CENTER

NIH RePORTER

OtherR44Completed

Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)

Stewart, Charles·CARTESIAN THERAPEUTICS, INC.·Gaithersburg, MD

$1,496,118 (FY2025)

NIH RePORTER

NIH Grants & Funding for Polyneuropathy | Kisho | Kisho

Kisho

Polyneuropathy — NIH Grants & Funding

Funding Landscape

By Research Theme

Funding by Fiscal Year

By Funding Mechanism

Funding Gap Analysis

Adjacent Research(15 grants)

Other(15)

The Role of Tau Phosphorylation in Diabetic Peripheral Neuropathy

Uncovering early signals of hereditary TTR amyloidosis in minority populations at high genetic risk

Modulation of CSF1R Signaling to Treat Inflammatory Neuropathies

The role of SARM1 in neuroinflammation-mediated axonal damage

Cellular and Genetic Mechanisms of Autoimmune Diabetes Associated Neuritis

Mechanisms of Peripheral Nerve Injury and Recovery in a Zebrafish Demyelination Model

Ubiquitin Ligase TRIM39 Control of Zika Virus Infection

Development of ganglioside specific IgGs for the treatment of Guillian-Barré Syndrome

Mechanisms of Pain and Immune Processes

Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)

Top Funded Institutions

Top Principal Investigators